| Journal | American journal of preventive medicine |
| Study Type | Clinical Study |
| Population | Human participants |
This is the first nationally representative study to examine medically recommended cannabis use in US adolescents, providing critical baseline data as medical cannabis programs expand. Understanding the prevalence and correlates of medical versus non-medical use in this vulnerable population informs clinical decision-making and policy development.
This cross-sectional analysis of 2021-2023 National Survey on Drug Use and Health data examined 3,906 adolescents aged 12-17 with past-year cannabis use. Among cannabis-using adolescents, 5.2% reported healthcare professional-recommended use. The study compared sociodemographic factors, cannabis use disorder rates, and other substance use between medically recommended and non-medical users. Multivariable regression models assessed associations with cannabis use disorder and concurrent substance use, controlling for demographic variables.
“While 5.2% may seem low, this represents thousands of adolescents receiving medical cannabis recommendations nationally. The critical question this study begins to address is whether medical recommendations alter risk profiles compared to non-medical use.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
Table of Contents
- FAQ
- How common is medically recommended cannabis use among adolescents?
- Does medical cannabis recommendation protect adolescents from developing cannabis use disorder?
- Should healthcare providers be concerned about other substance use in adolescents prescribed medical cannabis?
- What are the clinical implications for prescribing medical cannabis to adolescents?
- How should this research influence clinical practice regarding adolescent medical cannabis?
FAQ
How common is medically recommended cannabis use among adolescents?
Based on this nationally representative study, only 5.2% of adolescents who used cannabis in the past year reported that it was medically recommended by a healthcare professional. This represents a small fraction of overall adolescent cannabis use, suggesting most teen cannabis use remains non-medical.
Does medical cannabis recommendation protect adolescents from developing cannabis use disorder?
No, the study found no protective effect from medical recommendations. Adolescents using medically recommended cannabis had similar rates of cannabis use disorder compared to those using cannabis non-medically. This suggests medical recommendation alone does not prevent problematic use patterns in teens.
Should healthcare providers be concerned about other substance use in adolescents prescribed medical cannabis?
Yes, the study found that adolescents using medically recommended cannabis showed similar patterns of other substance use as those using cannabis non-medically. This indicates a need for comprehensive substance use screening and monitoring in adolescents receiving medical cannabis recommendations.
What are the clinical implications for prescribing medical cannabis to adolescents?
Healthcare providers should exercise extreme caution when considering medical cannabis for adolescents, as this study shows no reduction in addiction risk compared to non-medical use. Careful risk-benefit analysis, close monitoring, and consideration of alternative treatments should be prioritized given the developing adolescent brain’s vulnerability.
How should this research influence clinical practice regarding adolescent medical cannabis?
This early-stage evidence suggests that medical cannabis recommendations in adolescents may not provide the safety profile previously assumed. Clinicians should implement rigorous monitoring protocols and consider this data when weighing treatment options, though more research is needed before definitive practice changes.